Could a cream replace surgery for face melanoma?

NCT ID NCT02723721

Completed Disease control Sponsor: Centre Hospitalier Universitaire de Nice Source: ClinicalTrials.gov ↗

First seen Mar 26, 2026 · Last updated May 18, 2026 · Updated 10 times

Summary

This study tested a gel called Picato (ingenol mebutate) on 20 people with a very early form of skin cancer called lentigo maligna on the face. Participants either could not have surgery or chose not to. The gel was applied to the skin to see if it could make the cancer go away. After one or two rounds of treatment, doctors checked if the cancer had completely cleared.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LENTIGO MALIGNA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Show contact details

Locations

AP-HP Hopital Avicenne

Bobigny, 93000, France
AP-HP Hôpital Ambroise Paré

Boulogne-Billancourt, France
CHRU de Lille

Lille, France
CHU de Nantes

Nantes, France
CHU de Nice

Nice, 06000, France
CHU de Saint Etienne

Saint-Etienne, France
Hôpital Pontchaillou

Rennes, France
Hôpital du Morvan

Brest, France

Conditions

Explore the condition pages connected to this study.

LENTIGO MALIGNA